Village Farms Acquires Remainder Of Pure Sunfarms For C$79.9 Million
Well, it looks like Raymond James was on to something. This afternoon, it was announced that Village Farms (TSX: VFF)
Read more
Emerald Health
Emerald Health Sells Quebec Subsidiaries For $21.0 Million In Cash
Emerald Health Therapeutics (TSXV: EMH) is leaving Quebec. The company announced this morning that it is selling its Quebec-based subsidiaries
Read more
Emerald Health Sees Revenues Decline 32% To $2.9 Million In First Quarter 2020
Revenues continue to decline for Emerald Health Therapeutics (TSXV: EMH), with the firm posting first quarter revenues of $2.9 million
Read more
Village Farms Settles Dispute With Emerald Health, Acquires Majority Ownership In Pure Sunfarms
Village Farms (TSX: VFF) (NASDAQ: VFF) and Emerald Health Therapeutics (TSXV: EMH) have finally come to a settlement agreement in
Read more
Pure Sunfarms Top Brand In Ontario, Enters Alberta
Pure Sunfarms, the cannabis joint venture between that of Village Farms (TSX: VFF) (NASDAQ: VFF) and Emerald Health Therapeutics (TSXV:
Read more
Emerald Health Issues Shares To Settle Debt With Subsidiary
Emerald Health Therapeutics (TSXV: EMH) is charging ahead with its previously announced shares for debt transaction with that of its
Read more
Village Farms Requests $5.94 Million Refund From Pure Sunfarms
It appears that Village Farms (TSX: VFF) (NASDAQ: VFF) is taking a step back from the battle it began with
Read more
Valens Company Announces Extraction Arrangement with Emerald Health
The Valens Company (TSXV: VLNS) announced this morning two new multi-year agreements for extraction services. The first, with Emerald Health
Read more
Emerald Health Announces Another Financing Below Market Rates, Dilutes Sciences Ownership
Emerald Health Therapeutics (TSXV: EMH) is raising money less than a month after it closed its previous financing. This time
Read more
Emerald Health Posts Loss of $17.5 Million For Quarter, Conference Call Sees Investor Vent Frustrations with Management
Emerald Health Therapeutics (TSXV: EMH) released its third quarter financial statements late Friday night, revealing a pending cash crunch at
Read more